Reduced virulence of rifampicin-resistant mutants of Francisella tularensis.
Rifampicin-resistant mutants of a live vaccine strain (LVS) of Francisella tularensis were produced and screened for virulence in mice; 4 avirulent clones with intraperitoneal (ip) LD50s > 10(6) cfu, compared with 10(2) cfu for LVS, were characterized. Growth characteristics at 37 degrees C, surface envelope proteins, and lipopolysaccharide profiles of resistant mutants were identical to those of LVS. Polymerase activity of the mutants was more resistant than the enzyme from LVS to the inhibitory action of rifampicin. Growth rates for mutants and LVS were similar during the first 5 h at 42 degrees C, but viability of the mutants decreased to < 0.01% at 24 h. LVS and mutants differed in their ability to grow in vitro in host macrophages: LVS increased 580-fold over 72 h; mutants increased 33-fold. After ip inoculation of the organisms into mice, increasing numbers of LVS from peritoneal cells were isolated; mutants decreased over 4 days.
Bhatnagar
N
N
Department of Cellular Immunology, Walter Reed Army Institute of Research, Washington, D.C.
Getachew
E
E
Straley
S
S
Williams
J
J
Meltzer
M
M
Fortier
A
A
D000818:Animals; D002478:Cells, Cultured; D012321:DNA-Directed RNA Polymerases / Q000378:metabolism; D004352:Drug Resistance, Microbial; D004926:Escherichia coli / Q000187:drug effects; D005604:Francisella tularensis / Q000187:drug effects / Q000235:genetics / Q000472:pathogenicity*; D017737:Macrophages, Peritoneal / Q000382:microbiology; D008297:Male; D051379:Mice; D008810:Mice, Inbred C57BL; D016296:Mutagenesis; D012293:Rifampin / Q000494:pharmacology*; D014774:Virulence / Q000187:drug effects* / Q000235:genetics
D012321:DNA-Directed RNA Polymerases; D012293:Rifampin